Pharmacological modulation of CXCL12/CXCR4/ACKR3 for brain disorders - an overview
Amandine Kuppens1, Bernard Rogister1,2, Virginie Neirinckx3
1Laboratory of Nervous System Disorders and Therapy, GIGA Institute, University of Liège, Liège, 4000, Belgium.
Cell Communication and Signaling : CCS
|April 23, 2026
Abstract
No abstract available in PubMed .
Keywords:
Alzheimer’s diseaseAmyotrophic lateral sclerosisChemokinesMultiple sclerosisNeuro-oncologyNeuroinflammationParkinson’s diseaseMore Related Videos
04:43Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
Published on: June 16, 2023
1.7K
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
13.4K
